These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 17898647

  • 1. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F, Franchon E, Kraoul L, Garciau I, Brovedani S, Tabaouti K, Landré E, Chassoux F, Paubel P, Piketty ML.
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [Abstract] [Full Text] [Related]

  • 2. Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring.
    Matar KM.
    J Pharm Biomed Anal; 2008 Nov 04; 48(3):822-8. PubMed ID: 18603399
    [Abstract] [Full Text] [Related]

  • 3. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Epilepsy Behav; 2007 Mar 04; 10(2):296-303. PubMed ID: 17317325
    [Abstract] [Full Text] [Related]

  • 4. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ, Amina S, Pita I, Bergey GK, Werz MA.
    Neurology; 2008 May 27; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [Abstract] [Full Text] [Related]

  • 5. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul 27; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 6. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
    Giroux PC, Salas-Prato M, Théorêt Y, Carmant L.
    Seizure; 2009 Oct 27; 18(8):559-63. PubMed ID: 19546014
    [Abstract] [Full Text] [Related]

  • 7. In situ metabolism of levetiracetam in blood of patients with epilepsy.
    Patsalos PN, Ghattaura S, Ratnaraj N, Sander JW.
    Epilepsia; 2006 Nov 27; 47(11):1818-21. PubMed ID: 17116020
    [Abstract] [Full Text] [Related]

  • 8. An initial experience with therapeutic drug monitoring of levetiracetam as reported from a pediatric clinical setting in India.
    Mathew BS, Fleming DH, Thomas M, Prabha R, Saravanakumar K.
    Neurol India; 2012 Nov 27; 60(2):146-9. PubMed ID: 22626693
    [Abstract] [Full Text] [Related]

  • 9. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J, Peltola M, Auvinen A, Keränen T, Liimatainen S, Kharazmi E, Fallah M.
    Acta Neurol Scand; 2008 May 27; 117(5):332-6. PubMed ID: 18081915
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N, Boero G, Michelucci R, Gambardella A, Giallonardo AT, Fattouch J, Di Bonaventura C, de Palo A, Ladogana M, Lamberti P, Vigevano F, La Neve A, Specchio LM.
    Epilepsia; 2008 Apr 27; 49(4):663-9. PubMed ID: 18266754
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G.
    Epilepsia; 2009 May 27; 50(5):1150-7. PubMed ID: 19175400
    [Abstract] [Full Text] [Related]

  • 18. Levetiracetam use in pregnancy.
    Longo B, Forinash AB, Murphy JA.
    Ann Pharmacother; 2009 Oct 27; 43(10):1692-5. PubMed ID: 19690219
    [Abstract] [Full Text] [Related]

  • 19. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS, Dewey CW, Boothe DM, Barone G, Kortz GD.
    J Am Vet Med Assoc; 2008 Mar 15; 232(6):867-72. PubMed ID: 18341442
    [Abstract] [Full Text] [Related]

  • 20. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS.
    Epilepsy Res; 2007 Apr 15; 74(1):60-9. PubMed ID: 17270398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.